Mico Onco is a complementary nutritional supplement for the treatment of cancer patients. The goal of Mico Onco is to improve the quality of life and nutritional status through high drug levels in an exclusive format that facilitates ingestion and simplifies the dosing schedule.

Mico Onco, cancer survivor.

Mico Onco is the specific formula for the integrative treatment of cancer patients. This dietary supplement contains the highest concentration of bioactive substances from biological medicinal mushrooms Reishi (Ganoderma lucidum), mushrooms of the sun (Agaricus blazei) and maitake (Grifola frondosa).

Which natural bioactive substances does Mico Onco contain?

This supplement contains antioxidants, α- and β-glucans, essential amino acids, etc. and natural vitamins (E, A and D). Mico Onco also contains Camu-Camu (Myrciaria dubia).

Thanks to its high concentration, it contributes to the maintenance of an adequate nutritional status. The novel presentation (liquid vials and extract capsules) reduces the dosage of capsule extracts and facilitates swallowing.

A correct nutritional status of the patient helps

* Improve tolerance to treatments and / or reduce the resulting complications.

* Improve the response of our (immune) defense system to disease and reduce the associated risk.

* Increase physical activity, mobility etc. and reduce convalescence.

* promote a more appropriate psycho-emotional state, reduce depression, fatigue, anxiety, etc.

Maintain an adequate balance of the organism (homeostasis) and proper functioning of the organs and systems.

Pharmaceutical Quality Standards from Mico Onco

Certified excellence: ecological products that are free of maltodextrins, artificial colors, heavy metals and other toxic substances.

Standardized extracts: High concentration ratios with standards for bioactive substances.

Vegetable capsules: We do not use derivatives of animal origin.

Protected Against Time Capsules: Exclusive sealing and packaging system in a controlled atmosphere that prevents oxidation and retains the properties of the extracts over a long period of time.

Why take Mico-Onco?

Thanks to its high concentration, Mico-Onco contributes to maintaining an adequate nutritional status. The novel presentation (liquid vials and extract capsules) reduces the dosage regimen of certain protocols and facilitates swallowing.

A correct nutritional status helps with:

Improvement of tolerance to treatments and / or reduction of the resulting complications.

Improve the response of our (immune) defense system to diseases and thereby reduce the associated risk.

Increase physical activity, mobility etc. and reduce convalescence.

promote a more appropriate psycho-emotional state, reduce depression, fatigue, anxiety, etc.

Maintain an adequate balance of the organism (homeostasis) and proper functioning of organs and systems.

Pharmaceutical quality standards

Certified excellence: ecological products that are free of maltodextrins, artificial colors, heavy metals and other toxic substances.

Standardized extracts: High concentration ratios with standards for bioactive substances.

Vegetable capsules: We do not use derivatives of animal origin.

Protected Against Time Capsules: Exclusive sealing and packaging system in a controlled atmosphere that prevents oxidation and retains the properties of the extracts over a long period of time.

ingredients

Composition per capsule:

400 mg standardized bio-pure extract of Ganoderma lucidum in vegetable capsule.

Sealed capsule with antioxidant band.

Composition per vial:

1,200 mg of organic extract of Ganoderma lucidum;

1,500 mg of organic extract of Agaricus blazei;

1,500 mg of organic extract of Grifola frondosa;

250 mg organic Myrciaria dubia fruit, purified water, raw agave juice (RAW) and natural flavor.

Nutritional supplements / Hifas da Terra Cancer / Mico Once

Nutritional supplements / Hifas da Terra Cancer / Mico Once

Mico Once

HiPP organic

Follow us on facebook

Suravitasan

NATYSAL

DietMed

ESI

Experience the unique pleasure

The Tea House

Terezia

News

newsletter